vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Rimini Street, Inc. (RMNI). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $105.5M, roughly 1.8× Rimini Street, Inc.). Rimini Street, Inc. runs the higher net margin — 1.3% vs 0.9%, a 0.4% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 1.2%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 1.1%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Rimini Street, Inc. is a global provider of independent third-party support services for enterprise software products including Oracle and SAP platforms. It serves clients across multiple industries worldwide, delivering cost-effective support, maintenance, and consulting solutions that help businesses cut operational expenses while ensuring software performance and security.
FOLD vs RMNI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $105.5M |
| Net Profit | $1.7M | $1.4M |
| Gross Margin | 85.7% | 59.0% |
| Operating Margin | 8.6% | 4.6% |
| Net Margin | 0.9% | 1.3% |
| Revenue YoY | 23.7% | 1.2% |
| Net Profit YoY | -88.5% | -59.4% |
| EPS (diluted) | $0.00 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $105.5M | ||
| Q4 25 | $185.2M | $109.8M | ||
| Q3 25 | $169.1M | $103.4M | ||
| Q2 25 | $154.7M | $104.1M | ||
| Q1 25 | $125.2M | $104.2M | ||
| Q4 24 | $149.7M | $114.2M | ||
| Q3 24 | $141.5M | $104.7M | ||
| Q2 24 | $126.7M | $103.1M |
| Q1 26 | — | $1.4M | ||
| Q4 25 | $1.7M | $724.0K | ||
| Q3 25 | $17.3M | $2.8M | ||
| Q2 25 | $-24.4M | $30.3M | ||
| Q1 25 | $-21.7M | $3.4M | ||
| Q4 24 | $14.7M | $6.7M | ||
| Q3 24 | $-6.7M | $-43.1M | ||
| Q2 24 | $-15.7M | $-1.1M |
| Q1 26 | — | 59.0% | ||
| Q4 25 | 85.7% | 60.4% | ||
| Q3 25 | 88.5% | 59.9% | ||
| Q2 25 | 90.2% | 60.4% | ||
| Q1 25 | 90.7% | 61.0% | ||
| Q4 24 | 90.1% | 63.7% | ||
| Q3 24 | 90.6% | 60.7% | ||
| Q2 24 | 91.1% | 59.1% |
| Q1 26 | — | 4.6% | ||
| Q4 25 | 8.6% | 4.5% | ||
| Q3 25 | 20.3% | 4.2% | ||
| Q2 25 | -6.1% | 39.6% | ||
| Q1 25 | -6.3% | 9.0% | ||
| Q4 24 | 10.7% | 13.0% | ||
| Q3 24 | 15.3% | -47.4% | ||
| Q2 24 | 11.8% | -0.8% |
| Q1 26 | — | 1.3% | ||
| Q4 25 | 0.9% | 0.7% | ||
| Q3 25 | 10.2% | 2.7% | ||
| Q2 25 | -15.8% | 29.1% | ||
| Q1 25 | -17.3% | 3.2% | ||
| Q4 24 | 9.8% | 5.8% | ||
| Q3 24 | -4.8% | -41.2% | ||
| Q2 24 | -12.4% | -1.1% |
| Q1 26 | — | $0.01 | ||
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $0.06 | $0.03 | ||
| Q2 25 | $-0.08 | $0.32 | ||
| Q1 25 | $-0.07 | $0.04 | ||
| Q4 24 | $0.05 | $0.07 | ||
| Q3 24 | $-0.02 | $-0.47 | ||
| Q2 24 | $-0.05 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $132.2M |
| Total DebtLower is stronger | $392.7M | $56.4M |
| Stockholders' EquityBook value | $274.2M | — |
| Total Assets | $949.9M | $397.1M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $132.2M | ||
| Q4 25 | $293.5M | $120.0M | ||
| Q3 25 | $263.8M | $108.7M | ||
| Q2 25 | $231.0M | $101.3M | ||
| Q1 25 | $250.6M | $122.6M | ||
| Q4 24 | $249.9M | $88.8M | ||
| Q3 24 | $249.8M | $119.5M | ||
| Q2 24 | $260.1M | $134.2M |
| Q1 26 | — | $56.4M | ||
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $274.2M | $-27.0M | ||
| Q3 25 | $230.4M | $-27.3M | ||
| Q2 25 | $204.3M | $-29.0M | ||
| Q1 25 | $193.6M | $-63.7M | ||
| Q4 24 | $194.0M | $-69.4M | ||
| Q3 24 | $178.8M | $-76.8M | ||
| Q2 24 | $132.5M | $-36.1M |
| Q1 26 | — | $397.1M | ||
| Q4 25 | $949.9M | $423.1M | ||
| Q3 25 | $868.8M | $352.9M | ||
| Q2 25 | $815.3M | $397.5M | ||
| Q1 25 | $789.8M | $343.0M | ||
| Q4 24 | $785.0M | $369.1M | ||
| Q3 24 | $786.6M | $343.8M | ||
| Q2 24 | $749.5M | $367.4M |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $19.6M | ||
| Q3 25 | $35.7M | $24.7M | ||
| Q2 25 | $-26.5M | $-17.8M | ||
| Q1 25 | $7.8M | $33.7M | ||
| Q4 24 | $-3.9M | $-37.7M | ||
| Q3 24 | $-23.0M | $-18.5M | ||
| Q2 24 | $22.7M | $6.3M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $18.9M | ||
| Q3 25 | $35.3M | $23.5M | ||
| Q2 25 | $-28.9M | $-19.5M | ||
| Q1 25 | $7.5M | $32.8M | ||
| Q4 24 | $-4.2M | $-38.4M | ||
| Q3 24 | $-23.3M | $-19.2M | ||
| Q2 24 | $21.6M | $5.4M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 17.2% | ||
| Q3 25 | 20.9% | 22.7% | ||
| Q2 25 | -18.7% | -18.8% | ||
| Q1 25 | 6.0% | 31.5% | ||
| Q4 24 | -2.8% | -33.6% | ||
| Q3 24 | -16.5% | -18.3% | ||
| Q2 24 | 17.0% | 5.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 0.6% | ||
| Q3 25 | 0.2% | 1.2% | ||
| Q2 25 | 1.6% | 1.7% | ||
| Q1 25 | 0.2% | 0.9% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.9% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 27.02× | ||
| Q3 25 | 2.06× | 8.94× | ||
| Q2 25 | — | -0.59× | ||
| Q1 25 | — | 10.06× | ||
| Q4 24 | -0.27× | -5.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
RMNI
Segment breakdown not available.
